Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have been given an average rating of “Moderate Buy” by the nineteen brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seventeen have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $29.7647.

A number of equities analysts have issued reports on PHR shares. Canaccord Genuity Group decreased their price objective on Phreesia from $38.00 to $33.00 and set a “buy” rating for the company in a report on Tuesday, December 9th. Wells Fargo & Company assumed coverage on shares of Phreesia in a report on Thursday, January 8th. They set an “overweight” rating and a $30.00 target price on the stock. Royal Bank Of Canada started coverage on shares of Phreesia in a research note on Friday, January 9th. They issued a “moderate buy” rating and a $26.00 price target for the company. Robert W. Baird lowered their price target on shares of Phreesia from $31.00 to $25.00 and set an “outperform” rating for the company in a research report on Wednesday, December 10th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Phreesia from $32.00 to $29.00 and set an “overweight” rating on the stock in a report on Tuesday, December 9th.

Phreesia Stock Performance

Shares of PHR opened at $15.82 on Monday. The company has a 50-day simple moving average of $17.69 and a two-hundred day simple moving average of $22.82. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The firm has a market capitalization of $953.97 million, a PE ratio of -158.21 and a beta of 0.61. Phreesia has a one year low of $15.40 and a one year high of $32.76.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.11. The firm had revenue of $120.33 million during the quarter, compared to analyst estimates of $119.98 million. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The business’s revenue was up 12.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.25) EPS. On average, analysts anticipate that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Transactions at Phreesia

In other news, General Counsel Allison C. Hoffman sold 3,995 shares of the stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $65,358.20. Following the sale, the general counsel directly owned 169,661 shares of the company’s stock, valued at approximately $2,775,653.96. This represents a 2.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Evan Roberts sold 6,268 shares of the firm’s stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $102,544.48. Following the transaction, the insider owned 826,554 shares of the company’s stock, valued at $13,522,423.44. The trade was a 0.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 60,766 shares of company stock worth $1,013,817. Company insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Hedge funds have recently bought and sold shares of the company. Raymond James Financial Inc. grew its position in Phreesia by 2.7% during the 2nd quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock valued at $400,000 after purchasing an additional 375 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Phreesia by 2.8% in the second quarter. PNC Financial Services Group Inc. now owns 19,983 shares of the company’s stock worth $569,000 after buying an additional 540 shares in the last quarter. Diversified Trust Co lifted its stake in shares of Phreesia by 1.7% in the third quarter. Diversified Trust Co now owns 45,822 shares of the company’s stock worth $1,078,000 after buying an additional 780 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in shares of Phreesia by 9.9% during the second quarter. Oppenheimer Asset Management Inc. now owns 8,803 shares of the company’s stock valued at $251,000 after buying an additional 792 shares during the last quarter. Finally, Alliancebernstein L.P. increased its position in shares of Phreesia by 1.3% during the third quarter. Alliancebernstein L.P. now owns 62,712 shares of the company’s stock valued at $1,475,000 after acquiring an additional 812 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.